Post BNT162b2 mRNA COVID-19 vaccination Henoch-SchÓ§nlein Pupura.

Wang, Samuel Sherng Young

Wang, Samuel Sherng Young.

Wang SSY; Infectious Diseases, National Centre for Infectious Diseases, Singapore samuel.wang@mohh.com.sg.

Postgrad Med J ; 98(1166): 900-901, 2022 Dec.

Article in English | MEDLINE | ID: covidwho-2138045

Subject(s)

BNT162 Vaccine; COVID-19; Humans; COVID-19 Vaccines/adverse effects; RNA, Messenger; COVID-19/prevention & control; Vaccination

Keywords

COVID-19; adverse events; dermatology; immunology; rheumatology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / BNT162 Vaccine Topics: Vaccines Limits: Humans Language: English Journal: Postgrad Med J Year: 2022 Document Type: Article Affiliation country: Postgradmedj-2021-141407

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google